Search research articles
Contact Us
Filters
Showing results (1-10 of 24) with videos related to
Page
of 3
Sort By:
Circulation
|
July 15, 2015
Noninfectious Mitral Annular Disruption: An Unusual Complication of a 25-Meter Fall
Eli V Gelfand, Kamal Khabbaz
Current Heart Failure Reports
|
September 3, 2009
Cardiovascular magnetic resonance imaging for valvular heart disease
Angela Morello, Eli V Gelfand
Journal of the American College of Cardiology
|
August 15, 2006
Left atrial size and postoperative atrial fibrillation: the volume of evidence suggests it is time to break an old habit
Warren J Manning, Eli V Gelfand
The American Journal of Medicine
|
October 16, 2013
Valvular heart disease: classic teaching and emerging paradigms
D Marshall Brinkley, Eli V Gelfand
Journal of the American College of Cardiology
|
May 16, 2006
Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors
Eli V Gelfand, Christopher P Cannon
Expert Opinion on Investigational Drugs
|
March 1, 2006
Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors
Eli V Gelfand, Christopher P Cannon
Clinical Cardiology
|
October 31, 2012
Care of patients with apparently asymptomatic severe aortic valve stenosis
Mary Ann Williamson, Eli V Gelfand
American Heart Journal
|
February 5, 2004
Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT
Eli V Gelfand, Christopher P Cannon
Circulation
|
January 18, 2007
Images in cardiovascular medicine. Sinus of Valsalva aneurysm with right ventricular outflow tract obstruction: evaluation with Doppler, real-time 3-dimensional and contrast echocardiography
Eli V Gelfand, Dorota Bzymek, Michael T Johnstone
Critical Pathways in Cardiology
|
March 15, 2008
Venous thromboembolism guidebook
Eli V Gelfand, Gregory Piazza, Samuel Z Goldhaber
Page
of 3
Search research articles
Search
Showing results (1-10 of 24) with videos related to
Sort By:
Page
of 3
Circulation
|
July 15, 2015
Noninfectious Mitral Annular Disruption: An Unusual Complication of a 25-Meter Fall
Eli V Gelfand, Kamal Khabbaz
Current Heart Failure Reports
|
September 3, 2009
Cardiovascular magnetic resonance imaging for valvular heart disease
Angela Morello, Eli V Gelfand
Journal of the American College of Cardiology
|
August 15, 2006
Left atrial size and postoperative atrial fibrillation: the volume of evidence suggests it is time to break an old habit
Warren J Manning, Eli V Gelfand
The American Journal of Medicine
|
October 16, 2013
Valvular heart disease: classic teaching and emerging paradigms
D Marshall Brinkley, Eli V Gelfand
Journal of the American College of Cardiology
|
May 16, 2006
Rimonabant: a cannabinoid receptor type 1 blocker for management of multiple cardiometabolic risk factors
Eli V Gelfand, Christopher P Cannon
Expert Opinion on Investigational Drugs
|
March 1, 2006
Rimonabant: a selective blocker of the cannabinoid CB1 receptors for the management of obesity, smoking cessation and cardiometabolic risk factors
Eli V Gelfand, Christopher P Cannon
Clinical Cardiology
|
October 31, 2012
Care of patients with apparently asymptomatic severe aortic valve stenosis
Mary Ann Williamson, Eli V Gelfand
American Heart Journal
|
February 5, 2004
Antibiotics for secondary prevention of coronary artery disease: an ACES hypothesis but we need to PROVE IT
Eli V Gelfand, Christopher P Cannon
Circulation
|
January 18, 2007
Images in cardiovascular medicine. Sinus of Valsalva aneurysm with right ventricular outflow tract obstruction: evaluation with Doppler, real-time 3-dimensional and contrast echocardiography
Eli V Gelfand, Dorota Bzymek, Michael T Johnstone
Critical Pathways in Cardiology
|
March 15, 2008
Venous thromboembolism guidebook
Eli V Gelfand, Gregory Piazza, Samuel Z Goldhaber
Page
of 3